HLA-E and neuroblastoma: CD4 CTLs express not only the activating receptors NKG2C/E, but also the inhibitory receptor NKG2A, and these activating and inhibitory receptors NKG2C/E/A share the same ligand HLA-E expressed on neuroblastoma cells.